These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Increased serum low-density lipoprotein cholesterol in men treated short-term with the diuretic chlorthalidone. Glück Z; Weidmann P; Mordasini R; Bachmann C; Riesen W; Peheim E; Keusch G; Meier A Metabolism; 1980 Mar; 29(3):240-5. PubMed ID: 7374438 [TBL] [Abstract][Full Text] [Related]
4. Effects of indapamide and various diuretics alone or combined with beta-blockers on serum lipoproteins. Weidmann P; Bianchetti MG; Mordasini R Curr Med Res Opin; 1983; 8 Suppl 3():123-34. PubMed ID: 6137325 [TBL] [Abstract][Full Text] [Related]
5. The effect of chlorthalidone on serum lipids and lipoproteins. Rosenthal T; Holtzman E; Segal P Atherosclerosis; 1980 May; 36(1):111-5. PubMed ID: 7387770 [TBL] [Abstract][Full Text] [Related]
6. [The effect of diuretic therapy on serum lipoproteins: an undesirable effect?]. Glück Z; Weidmann P; Mordasini R; Peheim E; Bachmann C; Keusch G; Riesen W Schweiz Med Wochenschr; 1979 Jan; 109(4):104-8. PubMed ID: 219471 [TBL] [Abstract][Full Text] [Related]
7. Effects of treatment with diuretics on serum lipoproteins. Weidmann P; Gerber A J Cardiovasc Pharmacol; 1984; 6 Suppl 1():S260-8. PubMed ID: 6204152 [TBL] [Abstract][Full Text] [Related]
9. Serum lipoprotein levels during chlorthalidone therapy. A Veterans Administration-National Heart, Lung, and Blood Institute cooperative study on antihypertensive therapy: mild hypertension. Goldman AI; Steele BW; Schnaper HW; Fitz AE; Frohlich ED; Perry HM JAMA; 1980 Oct; 244(15):1691-5. PubMed ID: 6997522 [TBL] [Abstract][Full Text] [Related]
10. Reversal of diuretic-induced increases in serum low-density-lipoprotein cholesterol by the betablocker pindolol. Schiffl H; Weidmann P; Mordasini R; Riesen W; Bachmann C Metabolism; 1982 Apr; 31(4):411-5. PubMed ID: 7043175 [TBL] [Abstract][Full Text] [Related]
11. Do beta-blockers alter lipids and what are the consequences? Holtzman E; Rosenthal T; Goldbourt U; Segal P J Cardiovasc Pharmacol; 1987; 10 Suppl 2():S86-92; discussion S93. PubMed ID: 2481177 [TBL] [Abstract][Full Text] [Related]
12. Effects of chlorthalidone and metoprolol alone or in combination (logroton) on blood pressure, lipids, lipoproteins and circulating plasma ANF levels in essential hypertension. Bielmann P; Leduc G; Thibault G; Lepage J; Davignon J Int J Clin Pharmacol Ther Toxicol; 1991 Dec; 29(12):479-85. PubMed ID: 1839902 [TBL] [Abstract][Full Text] [Related]
14. Serum cholesterol during ketanserin and propranolol administration in hypertensive patients. Lijnen P; Fagard R; Staessen J; Blaton V; Hollez P; Rorive G; Amery A J Cardiovasc Pharmacol; 1987 Dec; 10(6):647-50. PubMed ID: 2450234 [TBL] [Abstract][Full Text] [Related]
15. Effects of antihypertensive therapy on serum lipoproteins. Weidmann P; Gerber A; Mordasini R Hypertension; 1983; 5(5 Pt 2):III120-31. PubMed ID: 6138309 [TBL] [Abstract][Full Text] [Related]
16. Long-term effects on plasma lipids of diet and drugs to treat hypertension. Treatment of Mild Hypertension Study (TOMHS) Research Group. Grimm RH; Flack JM; Grandits GA; Elmer PJ; Neaton JD; Cutler JA; Lewis C; McDonald R; Schoenberger J; Stamler J JAMA; 1996 May 22-29; 275(20):1549-56. PubMed ID: 8622245 [TBL] [Abstract][Full Text] [Related]
17. Alterations of plasma high-density lipoprotein cholesterol levels associated with consumption of selected medications. The Lipid Research Clinics Program Prevalence Study. Wallace RB; Hunninghake DB; Reiland S; Barrett-Connor E; Mackenthun A; Hoover J; Wahl P Circulation; 1980 Nov; 62(4 Pt 2):IV77-82. PubMed ID: 6106533 [TBL] [Abstract][Full Text] [Related]
18. The emerging problem of plasma lipid changes during antihypertensive therapy. Johnson BF J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S213-21. PubMed ID: 6177959 [TBL] [Abstract][Full Text] [Related]
19. Effect of antihypertensive agents on lipid metabolism. Cutler R Am J Cardiol; 1983 Feb; 51(4):628-31. PubMed ID: 6131603 [TBL] [Abstract][Full Text] [Related]
20. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia. Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R Artery; 1982; 10(4):266-85. PubMed ID: 7181672 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]